ArticleJournal of clinical medicine2024

Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX-Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective-Prospective Study.

Antonio Coppola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.